Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Lymphoma, Non-Hodgkin 17Dendritic Cell Sarcoma, Interdigitating 17Multiple Myeloma 16Lymphoma, Mantle-Cell 16Lymphoma, Large-Cell, Immunoblastic 16Lymphoma, Large B-Cell, Diffuse 16Lymphoma, Follicular 16Lymphoma, B-Cell, Marginal Zone 16Leukemia, Myeloid, Acute 16Leukemia, Lymphocytic, Chronic, B-Cell 16Hodgkin Disease 16Burkitt Lymphoma 16Recurrence 14Myelodysplastic Syndromes 14Myeloproliferative Disorders 13Congenital Abnormalities 13Neoplasms, Plasma Cell 12Lymphoma 12Leukemia, Myeloid, Accelerated Phase 12Leukemia 12Primary Myelofibrosis 10Leukemia, Myeloid, Chronic-Phase 10Blast Crisis 10Sezary Syndrome 9Mycosis Fungoides 9Lymphoma, T-Cell, Cutaneous 9Leukemia, Myelomonocytic, Juvenile 9Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 9Waldenstrom Macroglobulinemia 8

Interventions

Ifosfamide 30Methotrexate 29Doxorubicin 26Cyclophosphamide 24Cisplatin 22Filgrastim 18Etoposide 17Gemcitabine 16Leucovorin 14Magnetic Resonance Spectroscopy 11Temozolomide 10Specimen Handling 10cabozantinib 9apatinib 9X-Rays 9Carboplatin 9fludarabine 8Radiotherapy 8Nivolumab 8Neoadjuvant Therapy 8Irinotecan 8Granulocyte Colony-Stimulating Factor 8Drug Therapy 8Docetaxel 8Zoledronic Acid 7Vincristine 7Sirolimus 7Phantoms, Imaging 7Biopsy 7mifamurtide 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Osteosarcoma × Tacrolimus × Sarcoma × Clear all
NCT01804634 2026-03-13

Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Recruiting
60 enrolled
CNSGastrointestinalSarcoma

Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡